The antiretroviral drug atazanavir — sometimes included in treatments to prevent mother-to-child HIV transmission during pregnancy — may have small but significant effects on infant development, reports a new study.
The antiretroviral drug atazanavir — sometimes included in treatments to prevent mother-to-child HIV transmission during pregnancy — may have small but significant effects on infant development, reports a new study.